Clinical Trials Directory

Trials / Completed

CompletedNCT02770365

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
695 (actual)
Sponsor
Padagis LLC · Industry
Sex
Female
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To compare safety and efficacy of Perrigo's drug product compared to an FDA approved drug product in the treatment of vulvar and vaginal atrophy.

Conditions

Interventions

TypeNameDescription
DRUGestrace cream (Perrigo)
DRUGestrace cream (Reference)
DRUGPlacebo cream

Timeline

Start date
2016-05-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2016-05-12
Last updated
2021-11-02
Results posted
2020-08-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02770365. Inclusion in this directory is not an endorsement.